Anxiety symptoms

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87

Participation in an 8-week MBSR program was associated with significant decreases in both trait and state anxiety among trauma-exposed, primarily low-income women.

Effect: improvement; F(3, 35.13) = 10.87